Dr Feldman on the Background of the TRANSCEND CLL 004 Trial in CLL/SLL
Tatyana Feldman, MD, discusses the launch of the TRANSCEND CLL 004 trial in relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma.
Source: onclive.com
T Cell Lymphoma Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from T Cell Lymphoma Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In T Cell Lymphoma Program Today - Breaking & Trending Today
Cutaneous Lymphoma
Fred Hutchinson Cancer Center is one of few centers in the United States that has experience treating cutaneous lymphoma and specializes in providing novel therapies and clinical studies for this rare disease.
Source: fredhutch.org
CRISPR Therapeutics Presents Positive Results from its
-70% overall response rate (ORR) and 30% complete response (CR) rate in peripheral T-cell lymphoma (PTCL) and cutaneous T cell lymphoma (CTCL) at Dose...
Source: globenewswire.com